Cardiovascular risk of sleep apnoea and case report

Česká verzia

Authors: Jana Vyskočilová
Authors place of work: Spánková laboratoř plicního oddělení EUC Kliniky Plzeň
Published in the journal: Vnitř Lék 2017; 63(11): 843-847
Category: Reviews

Summary

The most frequently occurring sleep breathing disorders include sleep apnoea which in particular negatively affects quality of sleep, thereby affecting all organs in the body. Among the severe complications of untreated sleep apnoea are cardiovascular diseases including the most serious complication – sudden death in sleep due to a severe heart rhythm disorder.

Key words:
central sleep apnoea – cardiovascular diseases – obstructive sleep apnoea – sleep apnoea

Zdroje

1. Sánchez-de-la-Tirre M, Campos-Rodriguez F, Barbé F. Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med 2013; 1(1): 61–72. Dostupné z DOI: <http://dx.doi.org/10.1016/S2213–2600(12)70051–6>.

2. Riemann D,·Baum E, Cohrs S.-S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Kapitel „Insomnie bei Erwachsenen“ (AWMFRegisternummer 063–003). Update 2016. Somnologie 2017; 20(Suppl 2): 97–180. Dostupné z DOI: <https://doi.org/10.1007/s11818–016–0093–1>.

3. O´Connor JM. Trace elements and DNA damage. Biochem Soc Trans 2001; 29(Pt 2): 354–357.

4. Ayas NT, FitzGerald JM, Fleetham JA et al. Cost-effectivness of continuous positive airway pressure therapy for moderate to severe sleep apnoea/hypopnoea. Arch Intern Med 2006; 166(9): 977–984.

5. Gami AS, Howard DE, Olson EJ et al. Obstructive sleep apnea and the risk of Sudden cardiac death: a longitudinal study of 10 701 adults. J Am Coll Cardiol 2013; 62(7): 610–616. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jacc.2013.04.080>.

6. Drager LF, Bortolotto LA, Figueiredo AC et al. Effects of continuous positive airway pressure on early signs of aterosclerosis in obstructive sleep apnea. Am J Resir Crit Care Med 2007; 176(7): 706–712.

7. Young T, Finn L, Peppard PE et al. Sleep disordered breathing and mortality: eighteen-year follow up of the Wisconsin sleep cohort. Sleep 2008; 31(8): 1071–1078.

8. Goldstein C, Zee PC. Obstructive Sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Resp Crit Care Med 2010; 182(10): 1332–1333. Dostupné z DOI: <https://doi.org/10.1164/ajrccm.182.10.1332a>.

9. Parra O, Sánchez-Armengol A, Bonnin M et al. Early treatment of obstructive apnoea and stroke outcome. A randomised controlled trial. Eur Respir J 2011; 37(5): 1128–36. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00034410>.

10. Dong JY, Zhang YH, Quin LQ. Obstructive sleep apnea and cardiovascular risk: metaanalysis of prospective cohort studies. Atherosclerosis 2013; 229(2): 489–495. Dostupné z DOI: <http://dx.doi.org/10.1016/j.atherosclerosis.2013.04.026>.

11. Shah N, Redline S, Yaggi HK et al. Obstructive sleep apnea and Acute myocardial infarction severity, ischemic precondicioning? Sleep Breath 2013; 17(2): 819–826. Dostupné z DOI: <http://dx.doi.org/10.1007/s11325–012–0770–7>. Erratum in Sleep Breath 2013; 17(3): 1119.

12. Belaidi E, Joyeux-Faure M, Ribout C et al. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol 2009; 53(15): 1309–1317. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jacc.2008.12.050>.

13. Shahar E, Whitney CW, Redline S et al. Sleep disordered breathing and cardiovascular disease. Cross sectional results of the sleep heart health study. Am J Respir Crit Care Med 2001; 163(1): 19–25.

14. Corra U, Pistono M, Mezzani A et al. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and independence. Circulation 2006; 113(1): 44–50.

15. Kanagala R, Murali NS, Friedman PA et al. Obstructive sleep apnea and the recurrence of atrial fibrilation. Circulation 2003; 107(20): 2589–2594. Dostupné z DOI: <https://doi.org/10.1161/01.CIR.0000068337.25994.21>.